This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Bilikere Srinivasa Rao Dwarakanath (born 4 August 1955) is a molecular biologist and a radiation biologist, working on 2-Deoxy-D-glucose therapy in cancer research. His current research interests are experimental oncology, radiobiology, biological radioprotection and cell signaling in cancer therapy.[1] He is currently the Joint Director of the Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Head, Division of Radiation Biosciences, INMAS, and Adjunct Faculty at the Dr. B. R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi.[2]
Bilikere Srinivasa Rao Dwarakanath | |
|---|---|
| Born | 4 August 1955 |
| Nationality | Indian |
| Citizenship | India |
| Alma mater | Central College, Bangalore |
| Known for | Cancer Therapy and Radioprotection |
| Awards | Indira Vasudevan Award, Annual Award of SCRAC |
| Scientific career | |
| Fields | Biochemist and Radiation Biologist |
| Institutions | Institute of Nuclear Medicine and Allied Sciences |
| Doctoral advisor | Viney K Jain |
He is one of the members of the three-member committee (along with Prof. S.C. Pancholi of the Nuclear Science Centre and Prof. N.C. Goomer of Board of Radiation and Isotope Technology) that was constituted by the Delhi University to probe the incident of radioactivity leakage in a Delhi scrap market, the source of the radioactive material was traced to the chemistry department of the university.[3]
Early years edit
Dwarakanath was born in Bangalore, Karnataka, India, to B. N. Srinivasa Rao and B. S. Padmavathi as the third among 5 siblings. He obtained his B.Sc. degree in Physics, Chemistry and Mathematics from National College and his M.Sc. degree in Physics from Central College, Bangalore. He obtained his Ph.D. degree from Bangalore University, working at the National Institute of Mental Health and Neurosciences under the radiation biologist Viney K. Jain.
Institute of Nuclear Medicine and Allied Sciences edit
Dwarakanath joined INMAS, Delhi in April 1994 as "Scientist D".[4] He is currently the Joint Director and HOD, Division of Radiation Biosciences, at INMAS.[5] He has been advocating the use of 2-deoyx-D-glucose as an adjuvant to radiotherapy for the treatment of cancer.[6]
Professional Appointments edit
- Scientist G, Additional Director and Head, Division of Radiation Biosciences, INMAS, DRDO, Delhi – 2004 to present
- Scientist D, E and Head, Department of Biocybernetics, INMAS – 1994-2004
- Adjunct Faculty, ACBR, University of Delhi – 1999 to present
- Post-doctoral fellow, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA – 1989-1991
- Visiting Scientist, University of Duisburg-Essen, Germany – 1995
- Scientific Assistant, Scientific Officer and assistant professor, Department of Biophysics, NIMHANS, Bangalore – 1979-1994
References edit
- ^ Dwarakanath, B.S; Wallen, C.Anne; St. Clair, Daret K; Wheeler, Kenneth T (1991). "Characterization of nuclear matrices prepared without salt extraction". Analytical Biochemistry. 198 (1): 68–74. doi:10.1016/0003-2697(91)90507-P. PMID 1789433.
- ^ "B S Dwarakanath's Research on Deoxyglucose (2 Deoxy D glucose) | CureHunter". www.curehunter.com. Retrieved 23 July 2020.
- ^ "Dwarkanath". The Hindu. 29 April 2010.
- ^ "DRDO::INMAS". www.drdo.org. Archived from the original on 21 June 2010.
{{cite web}}: CS1 maint: unfit URL (link) - ^ "INMAS". DRDO. Archived from the original on 15 April 2010. Retrieved 23 July 2020.
{{cite web}}: CS1 maint: unfit URL (link) - ^ Dwarakanath, Bs (2009). "Targeting glucose metabolism with 2-deoxy- D -glucose for improving cancer therapy". Future Oncology. 5 (5): 581–585. doi:10.2217/fon.09.44. ISSN 1479-6694. PMID 19519197.